Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery

A single intravenous dose of tranexamic acid (15 mg/kg) was administered before surgery to assess its efficacy in reducing perioperative blood loss and the need for transfusion.

An equal volume of intravenous normal saline was administered as a placebo before surgery to compare outcomes with the tranexamic acid group.